newsfilter
← Latest News
FDA Approved Drugs·

Approval of Kisqali Femara Co-pack (copackaged), Nda #209935 (Efficacy)

Approval Date: 07/01/2026; Drug Name: Kisqali Femara Co-pack (copackaged), Nda #209935; Active Ingredients: LETROZOLE; RIBOCICLIB SUCCINATE; Company: Novartis; Submission Status: Approval; Submission Classification: Efficacy; Application Number: 209935

Company
NOVARTIS
Keywords
NOVARTIS